Rights issue in Bavarian Nordic (DK) — DKK 698 million Healthcare Rights issue in Bavarian Nordic (DK) — DKK 698 million
Acquisition of Københavns Energi (incl. 34 per cent stake in Energi E2) (DK) by DONG (DK) — DKK 10.5 billion Cleantech, Renewables & Infrastructure Acquisition of Københavns Energi (incl. 34 per cent stake in Energi E2) (DK) by DONG (DK) — DKK 10.5 billion
Public offer for Keops A/S (DK) by Fasteignafélagid Stodir Hf (IS) — Enterprise value DKK 21.5 billion Real Estate Public offer for Keops A/S (DK) by Fasteignafélagid Stodir Hf (IS) — Enterprise value DKK 21.5 billion
Acquisition of FIH (DK) by FöreningsSparbanken and other investors (SE) — DKK 6.6 billion FIG Acquisition of FIH (DK) by FöreningsSparbanken and other investors (SE) — DKK 6.6 billion
Private placement of equity in M&E Biotech A/S (DK) — DKK 32 million Healthcare Private placement of equity in M&E Biotech A/S (DK) — DKK 32 million
Secondary placing of shares in William Demant Invest (DK) — DKK 1.3 billion Healthcare Secondary placing of shares in William Demant Invest (DK) — DKK 1.3 billion
Divestment of Aktiv Gruppen (DK) to Olicom (DK) by EuroTrust A/S (DK) – DKK 969 million Cleantech, Renewables & Infrastructure Divestment of Aktiv Gruppen (DK) to Olicom (DK) by EuroTrust A/S (DK) – DKK 969 million
Acquisition of Schaumann Holding's 87 per cent ownership in Schaumann Development by Schaumann Properties (DK) — DKK 543 million Real Estate Acquisition of Schaumann Holding's 87 per cent ownership in Schaumann Development by Schaumann Properties (DK) — DKK 543 million
Merger of Realkredit Danmark (DK) and BG Bank (DK) — Amount not disclosed. FIG Merger of Realkredit Danmark (DK) and BG Bank (DK) — Amount not disclosed.
Initial public offering of M&E Biotech A/S (DK) — DKK 375 million Healthcare Initial public offering of M&E Biotech A/S (DK) — DKK 375 million
Acquisition by Alm. Brand A/S (DK) of non-life insurance business of Alm. Brand af 1792 G/S (DK) — DKK 578 million FIG Acquisition by Alm. Brand A/S (DK) of non-life insurance business of Alm. Brand af 1792 G/S (DK) — DKK 578 million
Initial public offering of Genmab A/S (DK) — DKK 1.6 billion Healthcare Initial public offering of Genmab A/S (DK) — DKK 1.6 billion